These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
76 related items for PubMed ID: 6619634
1. [Experimental study on active specific immunotherapy utilizing the immune reaction of irradiated tumor tissue. 7. Effect of the cryopreserved immunoreactive cells combined with PSK]. Ogawa Y, Maeda T, Yoshida S, Yamamoto Y, Morita M, Imanaka K, Gose K, Imajo Y, Kimura S. Nihon Gan Chiryo Gakkai Shi; 1983 Apr 20; 18(3):682-5. PubMed ID: 6619634 [No Abstract] [Full Text] [Related]
2. [Experimental study on active specific immunotherapy modified by irradiation. 6. Effect of active specific immunotherapy combined with non-specific immunopotentiator PS-K]. Imanaka K, Ogawa Y, Gose K, Imajo Y, Kimura S. Nihon Gan Chiryo Gakkai Shi; 1982 Dec 20; 17(8):2101-6. PubMed ID: 7169582 [No Abstract] [Full Text] [Related]
3. [Experimental studies on specific active immunotherapy using immune response of irradiated tumor tissues. 5. A combined effect of the immune response of cryopreserved tissue and OK-432]. Ogawa Y, Imanaka K, Gose K, Imajo Y, Kimura S. Nihon Gan Chiryo Gakkai Shi; 1982 Aug 20; 17(5):1305-10. PubMed ID: 7153622 [No Abstract] [Full Text] [Related]
4. [Experimental study on active specific immunotherapy utilizing the immune reaction of low-dose irradiated tumor tissue. 9. Effect of the mitomycin C-treated, cryopreserved immune reaction combined with biological response modifier, OK-432]. Ogawa Y, Maeda T, Yoshida S, Yamamoto Y, Morita M, Ogawa Y, Imanaka K, Gose K, Imajo Y, Kimura S. Nihon Gan Chiryo Gakkai Shi; 1983 Jun 20; 18(4):946-50. PubMed ID: 6413627 [No Abstract] [Full Text] [Related]
6. [Experimental study on active specific immunotherapy utilizing the immune reaction of low-dose irradiated tumor tissue. 3. Effect of the cryopreserved immune reaction]. Ogawa Y, Imanaka K, Gose K, Imajo Y, Kimura S. Nihon Gan Chiryo Gakkai Shi; 1982 Aug 20; 17(5):1293-8. PubMed ID: 7153620 [No Abstract] [Full Text] [Related]
8. [Comparison of the effect of irradiated tumor tissue with that of irradiated tumor cells in active specific immunotherapy]. Ogawa Y, Maeda T, Yoshida S, Yamamoto Y, Morita M, Ogawa Y, Hiratsuka J, Imanaka K, Imajo Y, Kimura S. Nihon Gan Chiryo Gakkai Shi; 1983 Aug 20; 18(5):1181-8. PubMed ID: 6663171 [No Abstract] [Full Text] [Related]
9. [Experimental study on active specific immunotherapy utilizing the immune reaction of low-dose irradiated tumor tissue. 8. Effect of mitomycin C-treated active specific immunotherapy]. Imanaka K, Gose K, Ichiyanagi A, Ashida C, Hamada F, Hashimura T, Takimoto S, Murakami M, Imajo Y, Kimura S. Nihon Gan Chiryo Gakkai Shi; 1983 Jun 20; 18(4):940-5. PubMed ID: 6413626 [No Abstract] [Full Text] [Related]
10. Combination therapy of radiation and immunomodulators in the treatment of MM46 tumor transplanted in C3H/He mice. Miyaji C, Ogawa Y, Imajo Y, Imanaka K, Kimura S. Oncology; 1983 Jun 20; 40(2):115-9. PubMed ID: 6828288 [Abstract] [Full Text] [Related]
11. [Effect of immunomodifier on radiation-induced antitumor immunity following local irradiation to tumor--2. Mouse interferon-alpha/beta]. Mukae S, Norimura T, Tsuchiya T. Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Oct 25; 48(10):1243-8. PubMed ID: 3222138 [No Abstract] [Full Text] [Related]
12. [Experimental study of the antitumor effect of Z-100 in the treatment of MM 46 tumor transplanted in C3H/He mice. 1. Effect of long-term administration of Z-100]. Ogawa Y, Inomata T, Yoshida S, Maeda T, Seguchi H. Nihon Gan Chiryo Gakkai Shi; 1988 Oct 20; 23(10):2551-8. PubMed ID: 3209924 [No Abstract] [Full Text] [Related]
13. [Experimental studies on active specific immunotherapy using the immune reaction of low-dose irradiated tumor tissues. Comparison of the effects of tumor cells and mononuclear cells]. Imanaka K, Tanaka K, Sasai K, Nishizawa S, Sano A, Kuroda Y, Ashida C, Gose K, Imajo Y, Kimura S. Nihon Gan Chiryo Gakkai Shi; 1984 Aug 20; 19(7):1438-42. PubMed ID: 6335162 [No Abstract] [Full Text] [Related]
15. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents. Kuhn S, Hyde EJ, Yang J, Rich FJ, Harper JL, Kirman JR, Ronchese F. J Immunol; 2013 Aug 15; 191(4):1984-92. PubMed ID: 23858033 [Abstract] [Full Text] [Related]
16. PSK immunotherapy in cancer patients--a preliminary report. Chung CH, Go P, Chang KH. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug 15; 20(3):210-6. PubMed ID: 3322700 [Abstract] [Full Text] [Related]
17. [Effect of an immunomodifier on radiation-induced antitumor immunity following local irradiation of the tumor--1. OK-432]. Mukae S, Norimura T, Tsuchiya T. Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Jun 25; 47(6):838-44. PubMed ID: 3684525 [No Abstract] [Full Text] [Related]
18. Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K. Yefenof E, Gafanovitch I, Oron E, Bar M, Klein E. Cancer Immunol Immunother; 1995 Dec 25; 41(6):389-96. PubMed ID: 8635197 [Abstract] [Full Text] [Related]
19. Active specific immunotherapy using the immune reaction of a low-dose irradiated tumor tissue. Ogawa Y, Imanaka K, Ashida C, Takashima H, Imajo Y, Kimura S. Int J Radiat Oncol Biol Phys; 1983 Apr 25; 9(4):533-7. PubMed ID: 6853254 [Abstract] [Full Text] [Related]
20. [Compound therapy including PSK for malignant head and neck cancer]. Hoshiya T, Matsunaga T, Hyo Y, Mori N, Kakiuchi H, Saeki K, Wakuda K. Gan To Kagaku Ryoho; 1982 Jan 25; 9(1):91-5. PubMed ID: 7184365 [Abstract] [Full Text] [Related] Page: [Next] [New Search]